SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-012017
Filing Date
2020-02-06
Accepted
2020-02-06 17:08:16
Documents
5
Effectiveness Date
2020-02-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm201696d2_defa14a.htm DEFA14A 31077
2 GRAPHIC image_001.jpg GRAPHIC 3645
3 GRAPHIC image_002.jpg GRAPHIC 2301
4 GRAPHIC proxycard_001.jpg GRAPHIC 572956
5 GRAPHIC proxycard_002.jpg GRAPHIC 433159
  Complete submission text file 0001104659-20-012017.txt   1426731
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-35023 | Film No.: 20583523
SIC: 2834 Pharmaceutical Preparations